Pharma Reviews: Muted topline Q3 growth in pharma note ban impact marginal

The pharmaceutical sector is expected to report a muted revenue growth of ... "We expect Indian pharma to report revenue growth of 12 per cent and ...
Read more: Muted topline Q3 growth in pharma note ban impact marginal